{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:11:47Z","timestamp":1791328307391,"version":"4.3.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.blre.2011.03.003","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T12:06:55Z","timestamp":1303301215000},"page":"147-153","source":"Crossref","is-referenced-by-count":38,"title":["Platelet-type Von Willebrand disease: Three decades in the life of a rare bleeding disorder"],"prefix":"10.1016","volume":"25","author":[{"given":"Maha","family":"Othman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2011.03.003_bb0005","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM198202113060603","article-title":"Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII\/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers","volume":"306","author":"Weiss","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2011.03.003_bb0010","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V60.3.790.790","article-title":"Platelet-type von Willebrand's disease: characterization of a new bleeding disorder","volume":"60","author":"Miller","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0015","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1172\/JCI111112","article-title":"von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease","volume":"72","author":"Miller","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2011.03.003_bb0020","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1073\/pnas.84.16.5615","article-title":"Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein","volume":"84","author":"Lopez","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2011.03.003_bb0025","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1073\/pnas.85.7.2135","article-title":"The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence","volume":"85","author":"Lopez","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2011.03.003_bb0030","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.90.18.8327","article-title":"Human platelet glycoprotein V: characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins","volume":"90","author":"Hickey","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2011.03.003_bb0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1182\/blood-2006-05-024091","article-title":"Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet","volume":"109","author":"Luo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0021-9258(19)40226-3","article-title":"Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding","volume":"265","author":"Vicente","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2011.03.003_bb0045","doi-asserted-by":"crossref","first-page":"15474","DOI":"10.1016\/S0021-9258(18)98640-0","article-title":"Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding","volume":"266","author":"Murata","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2011.03.003_bb0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1358\/dnp.2007.20.5.1120215","article-title":"The 14-3-3zeta-GPIb-IX-V complex as an antiplatelet target","volume":"20","author":"Andrews","year":"2007","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.blre.2011.03.003_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1357-2725(96)00122-7","article-title":"Molecular mechanisms of platelet adhesion and activation","volume":"29","author":"Andrews","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.blre.2011.03.003_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00062752-199704050-00005","article-title":"Structure and function of the glycoprotein Ib-IX-V complex","volume":"4","author":"Lopez","year":"1997","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0065","doi-asserted-by":"crossref","first-page":"13946","DOI":"10.1021\/bi00250a050","article-title":"Tyrosine sulfation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding","volume":"33","author":"Dong","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.blre.2011.03.003_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood.V99.1.145","article-title":"Functional analysis of the C-terminal flanking sequence of platelet glycoprotein Ib alpha using canine-human chimeras","volume":"99","author":"Shen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0075","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1182\/blood.V95.3.903.003k37_903_910","article-title":"Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex","volume":"95","author":"Shen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/09537100020019157","article-title":"Structural determinants within platelet glycoprotein Ibalpha involved in its binding to von Willebrand factor","volume":"11","author":"Cauwenberghs","year":"2000","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2011.03.003_bb0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0037-1615854","article-title":"The glycoprotein Ib-IX-V complex in platelet adhesion and signaling","volume":"82","author":"Andrews","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1054\/blre.1999.0116","article-title":"Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease","volume":"13","author":"Favaloro","year":"1999","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2011.03.003_bb0095","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1055\/s-0038-1650385","article-title":"Platelet-type von Willebrand disease","volume":"75","author":"Miller","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1538-7836.2005.01428.x","article-title":"Qualitative disorders of platelets and megakaryocytes","volume":"3","author":"Nurden","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2141.2006.06249.x","article-title":"2B or not 2B? Differential identification of type 2B, versus pseudo-von Willebrand disease","volume":"135","author":"Favaloro","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2008-1066019","article-title":"Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?","volume":"34","author":"Favaloro","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2141.2007.06850.x","article-title":"Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis","volume":"139","author":"Favaloro","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2141.2006.06411.x","article-title":"2B or not 2B? Differential identification of Type 2B, versus pseudo-,von Willebrand disease","volume":"136","author":"Whalley","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0125","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2007.06690.x","article-title":"Distinguishing between non-identical twins: platelet type and type 2B von Willebrand disease","volume":"138","author":"Othman","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0130","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-2007-1000368","article-title":"Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes","volume":"33","author":"Othman","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2141.2008.07171.x","article-title":"Differential identification of PT-VWD from type 2B VWD and GP1BA nomenclature issues","volume":"142","author":"Othman","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000275926","article-title":"Platelet-type von Willebrand disease: results of a worldwide survey from the Canadian PT-VWD project","volume":"123","author":"Othman","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0145","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2141.2006.06078.x","article-title":"Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance","volume":"133","author":"Enayat","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1751-553X.2007.00978.x","article-title":"Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease","volume":"30","author":"Franchini","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood.V63.1.226.226","article-title":"In vivo interaction of von Willebrand factor with platelets following cryoprecipitate transfusion in platelet-type von Willebrand's disease","volume":"63","author":"Miller","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0160","first-page":"104","article-title":"Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children","author":"Frontroth","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0165","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.2009.015990","article-title":"Diagnosis of platelet-type von Willebrand disease by flow cytometry","volume":"95","author":"Giannini","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2011.03.003_bb0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/bcmd.1997.0146","article-title":"Cloning of the murine platelet glycoprotein Ibalpha gene highlighting species-specific platelet adhesion","volume":"23","author":"Ware","year":"1997","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2011.03.003_bb0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF02602582","article-title":"Systematic screening for genetic polymorphism in human platelet glycoprotein Ibalpha","volume":"44","author":"Kaski","year":"1996","journal-title":"Immunogenetics"},{"key":"10.1016\/j.blre.2011.03.003_bb0180","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.V94.1.186.413k19_186_191","article-title":"Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex","volume":"94","author":"Afshar-Kharghan","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0185","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1365-2141.1998.01117.x","article-title":"New alleles of the platelet glycoprotein Ibalpha gene","volume":"103","author":"Corral","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0190","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1046\/j.1365-2141.2000.02479.x","article-title":"Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ib alpha with human platelet antigen-2 and variable number of tandem repeats polymorphism, and its relationship with coronary artery disease","volume":"111","author":"Ishida","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0037-1613098","article-title":"A novel polymorphism, 70Leu\/Phe, disrupts a consensus Leu residue within the leucine-rich repeat sequence of platelet glycoprotein Ibalpha","volume":"87","author":"Matsubara","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI115596","article-title":"NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145\/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens","volume":"89","author":"Kuijpers","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2011.03.003_bb0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<77::AID-AJH15>3.0.CO;2-Y","article-title":"A novel isoform of platelet glycoprotein Ib alpha is prevalent in African Americans","volume":"60","author":"Aramaki","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2011.03.003_bb0210","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1016\/S0021-9258(19)50199-5","article-title":"Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure\/function implications","volume":"267","author":"Lopez","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2011.03.003_bb0215","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.88.11.4761","article-title":"Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease","volume":"88","author":"Miller","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2011.03.003_bb0220","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V81.7.1787.1787","article-title":"Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor","volume":"81","author":"Russell","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0225","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood.V85.3.727.bloodjournal853727","article-title":"Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease","volume":"85","author":"Takahashi","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0230","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00001721-199707000-00009","article-title":"De novo mutation of the platelet glycoprotein Ib alpha gene in a patient with pseudo-von Willebrand disease","volume":"8","author":"Kunishima","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2011.03.003_bb0235","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1126\/science.107355","article-title":"Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain","volume":"297","author":"Huizinga","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.blre.2011.03.003_bb0240","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1172\/JCI116438","article-title":"Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment","volume":"91","author":"Murata","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2011.03.003_bb0245","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.V90.2.698","article-title":"Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239\u2013>Val) reported in patients with platelet-type von Willebrand disease","volume":"90","author":"Moriki","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0250","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1046\/j.1538-7836.2003.00369.x","article-title":"Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease","volume":"1","author":"Matsubara","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1160\/TH06-10-0579","article-title":"A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene","volume":"97","author":"Nurden","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0260","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1182\/blood-2002-09-2942","article-title":"Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease","volume":"105","author":"Othman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0265","doi-asserted-by":"crossref","first-page":"35657","DOI":"10.1074\/jbc.M205271200","article-title":"Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation","volume":"277","author":"Uff","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2011.03.003_bb0270","doi-asserted-by":"crossref","first-page":"23327","DOI":"10.1074\/jbc.M401659200","article-title":"Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations","volume":"279","author":"Dumas","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2011.03.003_bb0275","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1182\/blood-2009-03-210823","article-title":"Visualizing the von Willebrand factor\/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation","volume":"114","author":"Guerrero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2011.03.003_bb0280","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2353\/ajpath.2008.070417","article-title":"Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease","volume":"172","author":"Suva","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.blre.2011.03.003_bb0285","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2011.03.003_bb0290","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1160\/TH10-08-0523","article-title":"Frequency of Platelet type versus Type 2B von Willebrand Disease. An international registry-based study","volume":"105","author":"Hamilton","year":"2011","journal-title":"Thromb Haemost"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X11000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X11000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T23:15:24Z","timestamp":1637536524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X11000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0268960X11000233"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2011.03.003","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}